PL2228370T3 - N-{1-[3-(2-etoksy-5-(4-etylopiperazynylo)benzenosulfonylo)-4,5-dihydro-5-okso-1,2,4-triazyn-6-yl]etylo}butyroamid, sposób jego wytwarzania i zastosowanie - Google Patents

N-{1-[3-(2-etoksy-5-(4-etylopiperazynylo)benzenosulfonylo)-4,5-dihydro-5-okso-1,2,4-triazyn-6-yl]etylo}butyroamid, sposób jego wytwarzania i zastosowanie

Info

Publication number
PL2228370T3
PL2228370T3 PL07855873T PL07855873T PL2228370T3 PL 2228370 T3 PL2228370 T3 PL 2228370T3 PL 07855873 T PL07855873 T PL 07855873T PL 07855873 T PL07855873 T PL 07855873T PL 2228370 T3 PL2228370 T3 PL 2228370T3
Authority
PL
Poland
Prior art keywords
ethylpiperazinyl
butyramide
triazin
benzenesulfonyl
dihydro
Prior art date
Application number
PL07855873T
Other languages
English (en)
Inventor
Guanghui Tian
Zheng Liu
Jin Zheng
Jingshan Shen
Original Assignee
Topharman Shanghai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Topharman Shanghai Co Ltd filed Critical Topharman Shanghai Co Ltd
Publication of PL2228370T3 publication Critical patent/PL2228370T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL07855873T 2007-12-28 2007-12-28 N-{1-[3-(2-etoksy-5-(4-etylopiperazynylo)benzenosulfonylo)-4,5-dihydro-5-okso-1,2,4-triazyn-6-yl]etylo}butyroamid, sposób jego wytwarzania i zastosowanie PL2228370T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2007/003872 WO2009082845A1 (fr) 2007-12-28 2007-12-28 N-{1-[3-(2-éthoxy-5-(4-éthylpipérazinyl)benzènesulfonyl)-4,5-dihydro-5-oxo-1,2,4-triazin-6-yl]éthyl}butyramide, son procédé de préparation et son utilisation
EP07855873A EP2228370B1 (en) 2007-12-28 2007-12-28 N-{1-[3-(2-ethoxy-5-(4-ethylpiperazinyl)benzenesulfonyl)-4,5-dihydro-5-oxo-1,2,4-triazin-6-yl]ethyl}butyramide, the preparation method and use thereof

Publications (1)

Publication Number Publication Date
PL2228370T3 true PL2228370T3 (pl) 2012-10-31

Family

ID=40823747

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07855873T PL2228370T3 (pl) 2007-12-28 2007-12-28 N-{1-[3-(2-etoksy-5-(4-etylopiperazynylo)benzenosulfonylo)-4,5-dihydro-5-okso-1,2,4-triazyn-6-yl]etylo}butyroamid, sposób jego wytwarzania i zastosowanie

Country Status (7)

Country Link
US (1) US8410098B2 (pl)
EP (1) EP2228370B1 (pl)
JP (1) JP5411161B2 (pl)
BR (1) BRPI0722222A2 (pl)
ES (1) ES2388371T3 (pl)
PL (1) PL2228370T3 (pl)
WO (1) WO2009082845A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3388624B2 (ja) 1994-03-01 2003-03-24 本田技研工業株式会社 電動車両のバッテリ冷却装置
EP2448938B9 (en) 2009-06-29 2015-06-10 Incyte Corporation Pyrimidinones as pi3k inhibitors
US20120190849A1 (en) * 2009-08-07 2012-07-26 Ranbaxy Laboratories Limited Processes for the preparation of vardenafil
US8759359B2 (en) 2009-12-18 2014-06-24 Incyte Corporation Substituted heteroaryl fused derivatives as PI3K inhibitors
EP2655374B1 (en) 2010-12-20 2019-10-23 Incyte Holdings Corporation N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
PL3513793T3 (pl) 2011-09-02 2021-09-20 Incyte Holdings Corporation Heterocykloaminy jako inhibitory pi3k
AT512084A1 (de) 2011-10-20 2013-05-15 Univ Wien Tech Diazabicyclo- und diazaspiro-alkanderivate als phosphodiesterase-5 inhibitoren
CZ2011767A3 (cs) 2011-11-24 2013-06-05 Zentiva, K.S. Zpusob prípravy a izolace solí vardenafilu s kyselinami
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
WO2015191677A1 (en) 2014-06-11 2015-12-17 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
RS63963B1 (sr) 2015-02-27 2023-03-31 Incyte Holdings Corp Postupak pripreme pi3k inhibitora
WO2016183063A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Crystalline forms of a pi3k inhibitor
US9732097B2 (en) 2015-05-11 2017-08-15 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
CN107445964A (zh) * 2017-07-29 2017-12-08 合肥创新医药技术有限公司 一种盐酸伐地那非杂质的合成方法
AU2019277560B2 (en) 2018-06-01 2025-04-24 Incyte Corporation Dosing regimen for the treatment of PI3K related disorders
CN115785101B (zh) * 2022-11-23 2023-10-13 西安市食品药品检验所 一种含有苯基哌嗪结构的那非类化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL135462A0 (en) * 1997-11-12 2001-05-20 Bayer Ag 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
ES2223863T3 (es) * 2000-06-22 2005-03-01 Pfizer Inc. Procedimiento para la preparacion de pirazolopirimidinonas.
US6667398B2 (en) * 2000-06-22 2003-12-23 Pfizer Inc Process for the preparation of pyrazolopyrimidinones
DE10063108A1 (de) 2000-12-18 2002-06-20 Bayer Ag Verfahren zur Herstellung von Sulfonamid-substituierten Imidazotriazinonen
DE10063106A1 (de) 2000-12-18 2002-06-20 Bayer Ag Verfahren zur Herstellung von 2-(2-Ethoxyphenyl)-substituierten Imidazotriazinonen
WO2006127368A2 (en) * 2005-05-20 2006-11-30 Lexicon Genetics Incorporated Methods for synthesizing imidazotriazinones
CN103298786B (zh) * 2010-10-11 2016-01-20 埃克希金医药品有限公司 芳基磺酰胺盐ccr3拮抗剂

Also Published As

Publication number Publication date
ES2388371T3 (es) 2012-10-15
WO2009082845A1 (fr) 2009-07-09
EP2228370A1 (en) 2010-09-15
JP2011511761A (ja) 2011-04-14
EP2228370A4 (en) 2011-06-08
JP5411161B2 (ja) 2014-02-12
US8410098B2 (en) 2013-04-02
BRPI0722222A2 (pt) 2015-06-16
US20110190495A1 (en) 2011-08-04
EP2228370B1 (en) 2012-05-23

Similar Documents

Publication Publication Date Title
EP2228370A4 (en) N- {1- [3- (2-ETHOXY-5- (4-ETHYLPIPERAZINYL) BENZOLSULFONYL) -4,5-DIHYDRO-5-OXO-1,2,4-TRIAZIN-6-YL] ETHYL} BUTTERIC ACID AMID, PROCEDURE FOR THEIR MANUFACTURE AND ITS USE
HRP20170634T1 (hr) Kristalni oblici od 4-metil-n-[3-(4-metil-imidazol-1-il)-5-trifluorometil-fenil]-3-(4-piridin-3-il-pirimidin-2-ilamino)-benzamida
IL176872A0 (en) Amide derivatives, process for the preparation thereof and use thereof as an insecticide
IL191655A0 (en) Novel compounds, their preparation and use
ZA200800636B (en) Novel anti-IGF-IR antibodies and uses thereof
TWI366357B (en) Destination apparatus, and intermediate apparatus
IL184175A0 (en) Sulfonyl pyrrolidines, method for producing the same and their use as drugs
SI2561872T1 (sl) 3,5-disubstituirane in 3,5,7-trisubstituiran-3H-oksazolo in 3H-tiazolo(4,5-d)pirimidin-2-onske spojine in njihova predzdravila
IL185785A0 (en) Certain substituted amides, method of making, and method of use thereof
GB2427327B (en) Line-timing in packet-based networks
IL190460A0 (en) 4-oxy-n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
EP1741746A4 (en) METHOD OF MANUFACTURING RUBBER COMPOSITION, RUBBER COMPOSITION AND USE THEREOF
ZA200708818B (en) Antibacterial 5,5-disubstituted 3,3-dialkoxy-2,2-dihydroxy-1,1-biphenyl compounds and related methods
SI1926476T1 (sl) Amorfne trdne disperzije 7-kloro-N,N,5-trimetil-4-okso-3-fenil-3,5- dihidro-4H-piridazino/4,5-b/indol-1-acetamida
IL186936A0 (en) Hair tonic
EP1828305A4 (en) LOW LOSS PREIMPREGNE, COMPOSITIONS USEFUL FOR ITS PREPARATION AND USES THEREOF
EP1830858A4 (en) 3,6-BICYCLOLIDE
IL191067A0 (en) Micronised azodicarbonamide, the preparation and use thereof
EP1884514A4 (en) PROCESS FOR THE OPTICAL SEPARATION OF 2-AMINO-6 PROPYLAMINO-4,5,6,7-TETRAHYDROBENZOTHIAZOL AND INTERMEDIATE PRODUCTS
IL199239A0 (en) Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-
TWI367222B (en) Aminoquinoxaline compounds and polyaminoquinoxaline compounds, and use thereof
EP1788004A4 (en) NOVEL MODIFIED POLYMER, PROCESS FOR MANUFACTURING THE SAME, AND USE OF THE SAME NEW MODIFIED POLYMER
GB0425572D0 (en) 1,7-Naphthyridines
IL182445A0 (en) Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4difluoromethoxy-8-methanesulfona mido-dibenzo[b,d]furan-1-caboxamide
ZA200803627B (en) Polymers incorporating 1,3 and 1,4 cyclohexnedimethanol